Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Megumi Koyama"'
Autor:
Ayako Matsumura, Takuya Miyazaki, Takayoshi Tachibana, Taiki Ando, Megumi Koyama, Satoshi Koyama, Yoshimi Ishii, Hiroyuki Takahashi, Yuki Nakajima, Ayumi Numata, Wataru Yamamoto, Kenji Motohashi, Maki Hagihara, Kenji Matsumoto, Shin Fujisawa, Hideaki Nakajima
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 20-29 (2020)
Objective: A soluble form of suppression of tumorigenicity 2 (sST2) has emerged as a biomarker for acute graft-versus-host disease (GVHD) and non-relapse mortality (NRM). We prospectively monitored sST2 levels during the early phase of hematopoietic
Externí odkaz:
https://doaj.org/article/4b4bc0a7ebd54f418fa3fe9dadeb5d10
Autor:
Kenji Matsumoto, Shin Fujisawa, Taiki Ando, Megumi Koyama, Satoshi Koyama, Yoshimi Ishii, Ayumi Numata, Wataru Yamamoto, Kenji Motohashi, Maki Hagihara, Hideaki Nakajima
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 3, Pp 181-184 (2018)
Objective: Useful prognostic biomarkers for diffuse large B-cell lymphoma (DLBCL) patients have been reported. To determine the prognostic value of hemoglobin (Hb) level in DLBCL patients, we performed a retrospective study. Materials and Methods: We
Externí odkaz:
https://doaj.org/article/61caa6ee9ca54c87b71870e6bdee68b9
Autor:
Yuki Nakajima, Ayako Matsumura, Maki Hagihara, Hideaki Nakajima, Megumi Koyama, Hiroyuki Takahashi, Kenji Matsumoto, Wataru Yamamoto, Taiki Ando, Takuya Miyazaki, Shin Fujisawa, Ayumi Numata, Satoshi Koyama, Kenji Motohashi, Yoshimi Ishii, Takayoshi Tachibana
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 20-29 (2020)
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 20-29 (2020)
A soluble form of suppression of tumorigenicity 2 (sST2) has emerged as a biomarker for acute graft-versus-host disease (GVHD) and non-relapse mortality (NRM). We prospectively monitored sST2 levels during the early phase of hematopoietic stem cell t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14cd38403ed25f0e56433d10e485ddcc
http://europepmc.org/articles/PMC7057758
http://europepmc.org/articles/PMC7057758
Autor:
Taiki Ando, Megumi Koyama, Shin Fujisawa, Wataru Yamamoto, Kenji Motohashi, Satoshi Koyama, Hideaki Nakajima, Maki Hagihara, Kenji Matsumoto, Ayumi Numata, Yoshimi Ishii
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 35, Iss 3, Pp 181-184 (2018)
Turkish Journal of Hematology, Vol 35, Iss 3, Pp 181-184 (2018)
Useful prognostic biomarkers for diffuse large B-cell lymphoma (DLBCL) patients have been reported. To determine the prognostic value of hemoglobin (Hb) level in DLBCL patients, we performed a retrospective study.We evaluated disease outcome, progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d819b6ef1dec5869584f886803960305
https://doi.org/10.4274/tjh.2017.0437
https://doi.org/10.4274/tjh.2017.0437
Autor:
Megumi, Koyama, Ayumi, Numata, Yasufumi, Ishiyama, Hirotaka, Takasaki, Kouta, Washimi, Kae, Kawachi, Tomoyuki, Yokose, Naoya, Nakamura, Rika, Sakai, Hideaki, Nakajima
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 58(7)
A 73-year-old woman presented a 3-year history of indolent enlargement of cutaneous tumor nodules. Peripheral blood flow cytometry revealed thrombocytopenia (platelets; 85,000/µl) and the presence of an abnormal, small B lymphocyte population (CD5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a864934a0dd0ea4d33b383f4149e595a
https://pubmed.ncbi.nlm.nih.gov/28781269
https://pubmed.ncbi.nlm.nih.gov/28781269
Autor:
Yuki Nakajima, Megumi Koyama, Maki Hagihara, Wataru Yamamoto, Taiki Ando, Hiroyuki Takahashi, Ayumi Numata, Kenji Matsumoto, Takuya Miyazaki, Kenji Motohashi, Hideaki Nakajima, Satoshi Koyama, Ayako Matsumura, Yoshimi Ishii, Takayoshi Tachibana, Shin Fujisawa
Publikováno v:
Blood. 134:1976-1976
Background: A soluble form of suppression of tumorigenicity 2 (ST2) has emerged as a biomarker for acute graft-versus-host disease (GVHD) and non-relapse mortality (NRM), whereas a clinical role of ST2 during the early phase of hematopoietic stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5d809c79a8b8ab2184ce067a3118a5e
https://doi.org/10.1182/blood-2019-123262
https://doi.org/10.1182/blood-2019-123262
Publikováno v:
2010 First IEEE International Conference on Smart Grid Communications.
Renewable, natural, and distributed power sources have been adopted in order to reduce consumption of fossil fuels. These new energy sources have fluctuations in the amount of output power, frequency, and voltage. Similar situation arises at the regu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34d1c3442486104b4a7fba46f617ff60
https://doi.org/10.1109/smartgrid.2010.5622079
https://doi.org/10.1109/smartgrid.2010.5622079